Answers are grounded in this paper and cite their sources.
BACKGROUND: Respiratory distress syndrome (RDS) is a serious complication of preterm birth and the primary cause of early neonatal mortality and disability. OBJECTIVE: To assess the effects on fetal and neonatal morbidity and mortality, on maternal mortality and morbidity, and on the child in later life of administering corticosteroids to the mother before anticipated preterm birth. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (October 30, 2005). SELECTION CRITERIA: Randomized controlled comparisons of antenatal corticosteroid administration (betamethasone, dexamethasone, or hydrocortisone) with placebo or with no treatment given to women with a singleton or multiple pregnancy, expected to deliver preterm as a result of either spontaneous preterm labor, preterm prelabor rupture of the membranes, or elective preterm delivery. DATA COLLECTION AND ANALYSIS: Two review authors assessed trial quality and extracted data independently. MAIN RESULTS: Twenty-one studies (3,885 women and 4,269 infants) are included. Treatment with antenatal corticosteroids does not increase risk to the mother of death, chorioamnionitis, or puerperal sepsis. Treatment with antenatal corticosteroids is associated with an overall reduction in neonatal death (relative risk [RR] 0.69, 95% confidence interval [CI] 0.58–0.81, 18 studies, 3,956 infants), RDS (RR 0.66, 95% CI 0.59–0.73, 21 studies, 4,038 infants), cerebroventricular hemorrhage (RR 0.54, 95% CI 0.43–0.69, 13 studies, 2,872 infants), necrotizing enterocolitis (RR 0.46, 95% CI 0.29–0.74, eight studies, 1,675 infants), respiratory support, intensive care admissions (RR 0.80, 95% CI 0.65–0.99, two studies, 277 infants), and systemic infections in the first 48 hours of life (RR 0.56, 95% CI 0.38–0.85, five studies, 1,319 infants). Antenatal corticosteroid use is effective in women with premature rupture of membranes and pregnancy-related hypertension syndromes. REVIEWERS' CONCLUSION: The evidence from this new review supports the continued use of a single course of antenatal corticosteroids to accelerate fetal lung maturation in women at risk of preterm birth. A single course of antenatal corticosteroids should be considered routine for preterm delivery with few exceptions. Further information is required concerning optimal dose-to-delivery interval, optimal corticosteroid to use, and effects in multiple pregnancies and to confirm the long-term effects into adulthood.
No takes yet. Share an insight, caveat, or question.
James P Neilson (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: